CN105531365A - 分离的幼稚多能干细胞和产生所述细胞的方法 - Google Patents

分离的幼稚多能干细胞和产生所述细胞的方法 Download PDF

Info

Publication number
CN105531365A
CN105531365A CN201480035892.7A CN201480035892A CN105531365A CN 105531365 A CN105531365 A CN 105531365A CN 201480035892 A CN201480035892 A CN 201480035892A CN 105531365 A CN105531365 A CN 105531365A
Authority
CN
China
Prior art keywords
naive
psc
inhibitor
cells
mbd3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480035892.7A
Other languages
English (en)
Chinese (zh)
Inventor
Y.汉纳
N.诺维斯特恩
Y.赖斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of CN105531365A publication Critical patent/CN105531365A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/605—Nanog
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201480035892.7A 2013-04-23 2014-04-23 分离的幼稚多能干细胞和产生所述细胞的方法 Pending CN105531365A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361814920P 2013-04-23 2013-04-23
US61/814920 2013-04-23
US201361878769P 2013-09-17 2013-09-17
US61/878769 2013-09-17
US201461932935P 2014-01-29 2014-01-29
US61/932935 2014-01-29
PCT/IB2014/060954 WO2014174470A1 (en) 2013-04-23 2014-04-23 Isolated naive pluripotent stem cells and methods of generating same

Publications (1)

Publication Number Publication Date
CN105531365A true CN105531365A (zh) 2016-04-27

Family

ID=50842281

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480035892.7A Pending CN105531365A (zh) 2013-04-23 2014-04-23 分离的幼稚多能干细胞和产生所述细胞的方法

Country Status (7)

Country Link
US (3) US10920192B2 (https=)
EP (1) EP2989199B1 (https=)
JP (1) JP2016521971A (https=)
CN (1) CN105531365A (https=)
ES (1) ES2831424T3 (https=)
IL (1) IL241930B (https=)
WO (1) WO2014174470A1 (https=)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107523540A (zh) * 2017-06-27 2017-12-29 香港大学深圳医院 一种建立家族遗传性卵巢早衰来源的诱导全能干细胞向原始生殖嵴细胞诱导分化的方法
CN108707629A (zh) * 2018-05-28 2018-10-26 上海海洋大学 斑马鱼notch1b基因突变体的制备方法
CN109355300A (zh) * 2018-11-26 2019-02-19 成都中医药大学 黄连sdir转录因子在提高植物抗旱中的应用
CN110050061A (zh) * 2016-10-05 2019-07-23 富士胶片细胞动力公司 从具有MeCP2破坏的诱导多能干细胞生成成熟谱系
CN110564674A (zh) * 2019-09-29 2019-12-13 广东工业大学 一种干细胞铺底工作液及其应用
CN110592014A (zh) * 2019-08-14 2019-12-20 广东美赛尔细胞生物科技有限公司 一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
CN110646335A (zh) * 2019-09-29 2020-01-03 广东工业大学 一种封闭液及其应用
CN111487399A (zh) * 2020-03-26 2020-08-04 湖南师范大学 一种蛋白分子标记在鱼类生殖细胞发育研究中的应用
CN111650327A (zh) * 2020-07-16 2020-09-11 扬州大学 一种基于非标定量蛋白质组学技术寻找如皋黄鸡不同细胞或组织间差异表达蛋白的方法
CN114164258A (zh) * 2021-12-22 2022-03-11 北京泽辉辰星生物科技有限公司 一种多能性基因表达水平检验方法
CN114651787A (zh) * 2022-04-21 2022-06-24 贵州医科大学附属医院 用于构建小鼠视神经特异性脱髓鞘模型的小鼠的构建方法及其应用
WO2022178986A1 (zh) * 2021-02-26 2022-09-01 澳门大学 一种诱导干细胞分化成中胚层谱系或滋养细胞谱系的方法及药物
CN117431258A (zh) * 2023-12-20 2024-01-23 上海元戊医学技术有限公司 使用含有Tet1基因的重编程因子诱导人体细胞重编程的方法

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
CN105531365A (zh) 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
KR102170502B1 (ko) 2013-12-11 2020-10-28 리제너론 파마슈티칼스 인코포레이티드 게놈의 표적화된 변형을 위한 방법 및 조성물
US20170114323A1 (en) 2014-06-19 2017-04-27 Whitehead Institute For Biomedical Research Uses of kinase inhibitors for inducing and maintaining pluripotency
CN108064274A (zh) 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
SG11201701398SA (en) * 2014-08-22 2017-03-30 Cambridge Entpr Ltd Resetting pluripotent stem cells
CN105441384B (zh) * 2014-09-26 2021-01-05 北京大学 一种制备动物和人类原始多潜能干细胞的方法，试剂盒及用途
BR112017007770A2 (pt) 2014-10-15 2018-01-16 Regeneron Pharma cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
US10745670B2 (en) 2014-11-17 2020-08-18 Genome Research Limited In vitro production of expanded potential stem cells
US20180071376A1 (en) 2015-03-23 2018-03-15 The Brigham And Women`S Hospital, Inc. Tolerogenic nanoparticles for treating diabetes mellitus
WO2016169903A1 (en) * 2015-04-23 2016-10-27 Koninklijke Philips N.V. Model-based segmentation of an anatomical structure
US20180142206A1 (en) * 2015-05-05 2018-05-24 The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads Reversion of primed pluripotent stem cells to naive pluripotent stem cells
US10563171B2 (en) * 2015-06-29 2020-02-18 Kyoto University Method for inducing differentiation of pluripotent stem cells into germ cells
WO2017025061A1 (en) * 2015-08-13 2017-02-16 Peking University Induced extended pluripotent stem cells, methods of making and using
CN108699515A (zh) 2016-02-24 2018-10-23 诺和诺德股份有限公司 由人多能干细胞衍生的内分泌祖细胞生成功能性β细胞
EP3438248A4 (en) * 2016-03-30 2019-11-06 Kyowa Hakko Bio Co., Ltd. NAIVES PLURIPOTENT STEM CELL CULTIVATION MEDIUM AND PLURIPOTENT STEM CELL CULTIVATION PROCEDURE
CN106244522A (zh) * 2016-08-12 2016-12-21 浙江译美生物科技有限公司 一种干细胞培养体系及其培养方法
CA3032972A1 (en) * 2016-08-19 2018-02-22 Memorial Sloan-Kettering Cancer Center Methods of differentiating stem cells into endoderm
GB201615343D0 (en) * 2016-09-09 2016-10-26 Zernicka-Goetz Magdalena And Harrison Sarah E M Methods
WO2018119213A1 (en) * 2016-12-23 2018-06-28 StemBios Technologies, Inc. Use of somatic stem cells for decreasing il-6 level
US11697796B2 (en) * 2017-01-23 2023-07-11 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells
US10783627B2 (en) * 2017-03-03 2020-09-22 Case Western Reserve University Predicting cancer recurrence using local co-occurrence of cell morphology (LoCoM)
WO2018209232A1 (en) * 2017-05-12 2018-11-15 Regents Of The University Of Minnesota Methods of preparing naive human pluripotent stem cells
ES2903187T3 (es) * 2017-06-13 2022-03-31 Georg August Univ Goettingen Stiftung Oeffentlichen Rechts Univsmedizin Procedimientos de producción de organoides neuronales de bioingeniería (BENO) y sus usos
MX2020005668A (es) 2017-11-30 2020-11-24 Univ Kyoto Metodo de cultivo de celulas.
KR102131921B1 (ko) * 2018-10-30 2020-07-08 차의과학대학교 산학협력단 줄기 세포의 신경전구세포로의 분화용 조성물, 키트, 및 이를 이용한 방법
EP3914698B1 (en) 2019-01-23 2024-12-11 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells
WO2021015228A1 (ja) * 2019-07-25 2021-01-28 富士フイルム株式会社 特定の分化細胞の製造方法
WO2021020267A1 (ja) * 2019-07-26 2021-02-04 富士フイルム株式会社 ナイーブ型多能性幹細胞の増殖能亢進用培地および多能性幹細胞の製造方法
EP4059572A4 (en) * 2019-11-14 2024-01-17 Shimasaki, Takeo CELLULAR REPROGRAMMING METHOD
US20230220331A1 (en) * 2020-03-24 2023-07-13 Jichi Medical University Temporary treatment medium, treatment kit, embryogenesis arrest inhibitor, embryogenesis arrest inhibitory method, developmental engineering product preparation method, transplantation method, therapeutic method, and developmental engineering product
TWI761837B (zh) * 2020-05-20 2022-04-21 國立中央大學 通用人類誘導多能性幹細胞及其生成方法
WO2021243252A1 (en) * 2020-05-29 2021-12-02 The Board Of Trustees Of The Leland Stanford Junior University Generation of primordial germ cells and methods of using the same
JP2023531963A (ja) * 2020-06-22 2023-07-26 ライフ テクノロジーズ コーポレーション 多能性細胞懸濁物を培養するための方法及び組成物
US20230250394A1 (en) * 2020-06-24 2023-08-10 Syracuse University Generation of perinatal-like mesenchymal stem cells from human induced pluripotent stem cells
CN112048467A (zh) * 2020-09-11 2020-12-08 江苏集萃药康生物科技有限公司 Ksom-aa培养液在体外培养nod背景鼠胚胎中的应用
US20230407245A1 (en) * 2020-11-11 2023-12-21 Bgi Shenzhen Group Holdings Co., Limited Media and methods for establishing and maintaining early embryo-like cells
WO2022114188A1 (ja) * 2020-11-30 2022-06-02 国立大学法人京都大学 二層性胚盤モデルおよびその製造方法
US12467917B2 (en) 2021-03-16 2025-11-11 California Institute Of Technology Reconstructing human early embryogenesis in vitro with pluripotent stem cells
WO2023082007A1 (en) * 2021-11-12 2023-05-19 L'alliance Boviteq Inc. Derivation of naïve bovine embryonic stem cells
WO2023173370A1 (en) * 2022-03-17 2023-09-21 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Media and methods for producing human cells and tissues from teratoma, organoids and embryoid bodies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102317442A (zh) * 2008-12-17 2012-01-11 斯克里普斯研究所 干细胞的产生和保持

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
IL68218A (en) 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
WO2003006950A2 (en) 2001-07-12 2003-01-23 Geron Corporation Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US20060194315A1 (en) 2003-03-31 2006-08-31 Condie Brian G Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
WO2006040763A2 (en) 2004-10-12 2006-04-20 Technion Research & Development Foundation Ltd. Isolated primate embryonic cells and methods of generating and using same
JP5680850B2 (ja) 2006-03-30 2015-03-04 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｏｕｒｔ ｏｆ ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｅｄｉｎｂｕｒｇｈ キナーゼインヒビターを含む培養培地およびその使用
CN105861443A (zh) 2007-04-07 2016-08-17 怀特黑德生物医学研究所 体细胞重编程
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
WO2010124290A2 (en) * 2009-04-24 2010-10-28 Whitehead Institute For Biomedical Research Compositions and methods for deriving or culturing pluripotent cells
US20130273649A1 (en) 2012-04-13 2013-10-17 University Of Southern California Culture medium for pluripotent stem cells
CN105531365A (zh) 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
CN108064274A (zh) 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
US10745670B2 (en) 2014-11-17 2020-08-18 Genome Research Limited In vitro production of expanded potential stem cells
US10246679B2 (en) 2015-03-02 2019-04-02 The University Of Tokyo Method for producing pluripotent stem cell having improved chimera forming ability from primed pluripotent stem cell, and composition and combination therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102317442A (zh) * 2008-12-17 2012-01-11 斯克里普斯研究所 干细胞的产生和保持

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
CHANTAL CERDAN等: "Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells", 《INT. J. DEV. BIOL.》 *
CHRISTOPHER J. LENGNER等: "Derivation of Pre-X Inactivation Human Embryonic Stem Cells under", 《CELL》 *
DEBASREE DUTTA等: "Self Renewal vs. Lineage Commitment of Embryonic Stem Cells:Protein Kinase C Signaling Shifts the Balance", 《STEM CELLS》 *
JACOB HANNA等: "Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs", 《PROC NATL ACAD SCI U S A》 *
JOERG BETSCHINGER等: "Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3", 《CELL》 *
KALAMEGAM GAUTHAMAN等: "Effect of ROCK Inhibitor Y-27632 on Normal and Variant Human Embryonic Stem Cells (hESCs) In Vitro: Its Benefits in hESC Expansion", 《STEM CELL REV AND REP》 *
KEISUKE KAJI等: "The NuRD component Mbd3 is required for pluripotency of embryonic stem cells", 《NATURE CELL BIOLOGY》 *
MASARU KATOH: "Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells", 《CURR PHARM BIOTECHNOL》 *
MERLIN NITHYA GNANAPRAGASAM等: "p66α–MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2–NuRD complex", 《PROC NATL ACAD SCI U S A》 *
PING XU等: "c-Jun NH2-Terminal Kinase Is Required for Lineage-specific Differentiation but Not Stem Cell Self-Renewal", 《MOLECULAR AND CELLULAR BIOLOGY》 *
SEAN C. BENDALL等: "IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro", 《NATURE》 *
TE LUDWIG等: "Feeder-independent culture of human embryonic stem cells", 《NATURE METHODS》 *
周一叶等: "维持胚胎干细胞多能性和自我更新的转录因子Oct-4/ Nanog以及相关的调控网络", 《HEREDITAS》 *
宋震涛等: "从早期胚胎多能干细胞生成的嵌合鼠", 《遗传学报》 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110050061A (zh) * 2016-10-05 2019-07-23 富士胶片细胞动力公司 从具有MeCP2破坏的诱导多能干细胞生成成熟谱系
CN107523540B (zh) * 2017-06-27 2021-02-12 香港大学深圳医院 一种建立家族遗传性卵巢早衰来源的诱导全能干细胞向原始生殖嵴细胞诱导分化的方法
CN107523540A (zh) * 2017-06-27 2017-12-29 香港大学深圳医院 一种建立家族遗传性卵巢早衰来源的诱导全能干细胞向原始生殖嵴细胞诱导分化的方法
CN108707629A (zh) * 2018-05-28 2018-10-26 上海海洋大学 斑马鱼notch1b基因突变体的制备方法
CN109355300A (zh) * 2018-11-26 2019-02-19 成都中医药大学 黄连sdir转录因子在提高植物抗旱中的应用
CN109355300B (zh) * 2018-11-26 2022-01-28 成都中医药大学 黄连sdir转录因子在提高植物抗旱中的应用
CN110592014A (zh) * 2019-08-14 2019-12-20 广东美赛尔细胞生物科技有限公司 一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
CN110564674A (zh) * 2019-09-29 2019-12-13 广东工业大学 一种干细胞铺底工作液及其应用
CN110564674B (zh) * 2019-09-29 2021-05-11 广东工业大学 一种干细胞铺底工作液及其应用
CN110646335A (zh) * 2019-09-29 2020-01-03 广东工业大学 一种封闭液及其应用
CN111487399A (zh) * 2020-03-26 2020-08-04 湖南师范大学 一种蛋白分子标记在鱼类生殖细胞发育研究中的应用
CN111487399B (zh) * 2020-03-26 2021-09-17 湖南师范大学 一种蛋白分子标记在鱼类生殖细胞发育研究中的应用
CN111650327A (zh) * 2020-07-16 2020-09-11 扬州大学 一种基于非标定量蛋白质组学技术寻找如皋黄鸡不同细胞或组织间差异表达蛋白的方法
WO2022178986A1 (zh) * 2021-02-26 2022-09-01 澳门大学 一种诱导干细胞分化成中胚层谱系或滋养细胞谱系的方法及药物
CN114164258A (zh) * 2021-12-22 2022-03-11 北京泽辉辰星生物科技有限公司 一种多能性基因表达水平检验方法
CN114651787A (zh) * 2022-04-21 2022-06-24 贵州医科大学附属医院 用于构建小鼠视神经特异性脱髓鞘模型的小鼠的构建方法及其应用
CN117431258A (zh) * 2023-12-20 2024-01-23 上海元戊医学技术有限公司 使用含有Tet1基因的重编程因子诱导人体细胞重编程的方法

Also Published As

Publication number Publication date
US10920192B2 (en) 2021-02-16
IL241930B (en) 2020-06-30
US20260028583A1 (en) 2026-01-29
ES2831424T3 (es) 2021-06-08
JP2016521971A (ja) 2016-07-28
EP2989199A1 (en) 2016-03-02
EP2989199B1 (en) 2020-08-12
US20140315301A1 (en) 2014-10-23
WO2014174470A1 (en) 2014-10-30
US20210253998A1 (en) 2021-08-19
US12570957B2 (en) 2026-03-10

Similar Documents

Publication Publication Date Title
US20260028583A1 (en) Isolated naive pluripotent stem cells and methods of generating same
Kinoshita et al. Capture of mouse and human stem cells with features of formative pluripotency
Romito et al. Pluripotent stem cells: current understanding and future directions
Gafni et al. Derivation of novel human ground state naive pluripotent stem cells
EP3183336B2 (en) Resetting pluripotent stem cells
Sakai et al. Induction of the germ cell fate from pluripotent stem cells in cynomolgus monkeys
JP7307481B2 (ja) 始原生殖細胞／始原生殖細胞様細胞の維持増幅及び分化誘導方法
Yuan et al. A six-inhibitor culture medium for improving naïve-type pluripotency of porcine pluripotent stem cells
CN105051188A (zh) 新颖方法
Kim et al. Conversion of genomic imprinting by reprogramming and redifferentiation
Pham et al. Efficient generation of germline chimeras in a non-rodent species using rabbit induced pluripotent stem cells
EP3408376B1 (en) Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
EP2501803B1 (en) Methods of enhancing pluripotentcy
Palma et al. Chromatin enhancer activity of IκBα mediates the exit from naïve pluripotency
Lasry et al. Fibroblasts-derived from Pluripotent Cells Harboring a Single Allele Knockout in Two Pluripotency Genes Exhibit DNA Methylation Abnormalities and pluripotency induction Defects
Gafni Delineating routes and applications of naive pluripotency
Mass List of Abbreviation
Bayerl Defining the Molecular and Functional Foundations of Novel Human Naive Pluripotent Stem Cells
Tobias Phenotypic and Metabolic Plasticity In Canine Cellular Reprogramming
Kearns Generation of Pharyngeal Foregut Endoderm from Pluripotent Stem Cells
Choi Dissecting Molecular Similarities and Differences Between Pluripotent Stem Cell Lines
Maherali Reprogramming cells to pluripotency by defined factors
Harness Characterization and Differentiation of Human Stem Cell Lines
Li PRMT5 is an essential survival factor for ground state pluripotency and primordial germ cells: From primordial germ cell differentiation in vitro to mammalian germline in vivo
Rezende Functional characterization of the stem cell biomarker Rex1 (Zpf42) in mouse embryonic stem cells, and in transgenic mouse models

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160427

WD01 Invention patent application deemed withdrawn after publication